Identification of a new AMPK activator for treatment of lung cancer

摘要

Identification of a new AMPK activator for treatment of lung cancer The present invention discloses a method of treating gefitinib-resistant non-small-cell lung cancer, comprising administering an effective amount of D561-0775. A pharmaceutical composition comprising D561-0775 admixed with a pharmaceutical carrier for treating Gefitinib-resistant non-small-cell lung cancer is also disclosed therein. 5- 0C) U)O